(Q40810900)

23 September 2017

Anti-inflammatory substances - a new therapeutic option in Alzheimer's disease (English)

1 reference

23 September 2017

0 references

Hüll M

1

1 reference

23 September 2017

Fiebich BL

2

1 reference

23 September 2017

Schumann G

3

1 reference

23 September 2017

Lieb K

4

1 reference

23 September 2017

Bauer J

5

1 reference

23 September 2017

1 June 1999

1 reference

23 September 2017

1 reference

23 September 2017

4

1 reference

23 September 2017

275-282

1 reference

23 September 2017

6

1 reference

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

APOE genotyping and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Apolipoprotein E alleles as risk factors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Glial cells in Alzheimer's disease: preferential effect of APOE risk on scattered microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

The toxicity in vitro of beta-amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Alzheimer's disease. Amyloid ox-tox transducers.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Lack of long-term effects after beta-amyloid protein injections in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Ultrastructural localization of argyrophilic substances in diffuse plaques of Alzheimer-type dementia demonstrated by methenamine silver staining

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Senile plaques do not progressively accumulate with normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Role of microglia in senile plaque formation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Microglial activation in early stages of amyloid beta protein deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Indomethacin reverses the microglial response to amyloid beta-protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Microglia are not exclusively associated with plaque-rich regions of the dentate gyrus in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Glial cytokines in Alzheimer's disease: review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

IL-6 detection in multiple sclerosis brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

beta-Amyloid peptide induced cytoskeletal reorganization in cultured astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Decreased expression of prostaglandin G/H synthase-2 (PGHS-2) in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Expression and regulation of cyclooxygenase-2 in rat microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Localization and cell association of C1q in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Early complement components in Alzheimer's disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Neuron loss in APP transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Glucocorticoids in Alzheimer's disease. The story so far.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Stress effects on morphology and function of the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Protective mechanisms of adenosine in neurons and glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Adenosine and propentofylline inhibit the proliferation of cultured microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

Clinical trials in dementia with propentofylline

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2899%2901339-2

7 January 2021

10.1016/S1359-6446(99)01339-2

Identifiers

DOI

1 reference

23 September 2017

1 reference